AJP - Endocrinology and Metabolism, Vol 263, Issue 1 E79-E84, Copyright © 1992 by American Physiological Society

ARTICLES

Effect of insulin on oxidative and nonoxidative pathways of free fatty acid metabolism in human obesity

L. C. Groop, R. C. Bonadonna, D. C. Simonson, A. S. Petrides, M. Shank and R. A. DeFronzo
Fourth Department of Medicine, Helsinki University Hospital, Finland.

The dose-response relationship between the plasma insulin concentration and oxidative and nonoxidative pathways of free fatty acid (FFA) metabolism was examined in 11 obese and 7 lean subjects using a stepwise insulin clamp technique in combination with indirect calorimetry and infusion of [1-14C]palmitate. The fasting plasma FFA concentration was elevated in obese subjects (793 +/- 43 vs. 642 +/- 39 mumol/l; P less than 0.01) and was associated with an increased basal rate of plasma FFA turnover, FFA oxidation, and nonoxidative FFA disposal, i.e., reesterification (all P less than 0.01). Suppression of plasma FFA turnover by physiological increments in plasma insulin was impaired in obese compared with lean subjects. However, plasma FFA turnover expressed per kilogram fat mass was normally suppressed by insulin in obese subjects. Although insulin suppressed plasma FFA oxidation to the same extent in lean and obese subjects, inhibition of total lipid oxidation by insulin was impaired in the obese group. Obese subjects had an enhanced basal rate of nonoxidative FFA disposal, which was suppressed less by physiological increments in plasma insulin compared with lean controls. Therefore, we conclude that 1) lipolysis in uncomplicated obesity is normally sensitive to insulin; the enhanced FFA flux is simply a consequence of the increased fat mass. 2) Nonoxidative FFA disposal expressed per lean body mass is enhanced in obese subjects and correlates with the increase in plasma FFA concentration and fat mass. 3) Enhanced oxidation of intracellular lipids contributes to the enhanced rate of total lipid oxidation in obese subjects.

This article has been cited by other articles:

				D. N. Reeds, B. Mittendorfer, B. W. Patterson, W. G. Powderly, K. E. Yarasheski, and S. Klein Alterations in lipid kinetics in men with HIV-dyslipidemia Am J Physiol Endocrinol Metab, September 1, 2003; 285(3): E490 - E497. [Abstract] [Full Text] [PDF]

				B. Mittendorfer, B. W. Patterson, S. Klein, and L. S. Sidossis VLDL-triglyceride kinetics during hyperglycemia-hyperinsulinemia: effects of sex and obesity Am J Physiol Endocrinol Metab, April 1, 2003; 284(4): E708 - E715. [Abstract] [Full Text] [PDF]

				E. Hagstrom-Toft, V. Qvisth, I. Nennesmo, M. Ryden, H. Bolinder, S. Enoksson, J. Bolinder, and P. Arner Marked Heterogeneity of Human Skeletal Muscle Lipolysis at Rest Diabetes, December 1, 2002; 51(12): 3376 - 3383. [Abstract] [Full Text] [PDF]

				E. Moberg, S. Sjoberg, E. Hagstrom-Toft, and J. Bolinder No apparent suppression by insulin of in vivo skeletal muscle lipolysis in nonobese women Am J Physiol Endocrinol Metab, August 1, 2002; 283(2): E295 - E301. [Abstract] [Full Text] [PDF]

				M. Stumvoll, H. G. Wahl, S. Jacob, A. Rettig, F. Machicao, and H. Haring Two novel prevalent polymorphisms in the hormone-sensitive lipase gene have no effect on insulin sensitivity of lipolysis and glucose disposal J. Lipid Res., November 1, 2001; 42(11): 1782 - 1788. [Abstract] [Full Text] [PDF]

				J. B. Albu, M. Curi, M. Shur, L. Murphy, D. E. Matthews, and F. X. Pi-Sunyer Systemic resistance to the antilipolytic effect of insulin in black and white women with visceral obesity Am J Physiol Endocrinol Metab, September 1, 1999; 277(3): E551 - E560. [Abstract] [Full Text] [PDF]

				S. Sreenan, S. Keck, T. Fuller, B. Cockburn, and C. F. Burant Effects of troglitazone on substrate storage and utilization in insulin-resistant rats Am J Physiol Endocrinol Metab, June 1, 1999; 276(6): E1119 - E1129. [Abstract] [Full Text] [PDF]

				C. Robinson, W. V. Tamborlane, D. G. Maggs, S. Enoksson, R. S. Sherwin, D. Silver, G. I. Shulman, and S. Caprio Effect of insulin on glycerol production in obese adolescents Am J Physiol Endocrinol Metab, April 1, 1998; 274(4): E737 - E743. [Abstract] [Full Text] [PDF]

				K. T. Stepniakowski, G. Lu, G. D. Miller, and B. M. Egan Fatty Acids, Not Insulin, Modulate {alpha}1-Adrenergic Reactivity in Dorsal Hand Veins Hypertension, November 1, 1997; 30(5): 1150 - 1155. [Abstract] [Full Text]

				B. M. Forman, J. Chen, and R. M. Evans Hypolipidemic drugs, polyunsaturated fatty acids, and eicosanoids are ligands for peroxisome proliferator-activated receptors alpha  and delta PNAS, April 29, 1997; 94(9): 4312 - 4317. [Abstract] [Full Text] [PDF]